Simplex Trading
ALXN

Simplex Trading’s Alexion Pharmaceuticals ALXN Stock Holding History

Simplex Trading’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-49,100
Closed -$47K – 10026
2021
Q2 		$47K Buy
49,100
+48,595
+9,623% +$8.34M ﹤0.01% 7727
2021
Q1 		$7.72M Sell
505
-258
-34% -$39.9K 0.01% 564
2020
Q4 		$11.9M Buy
+763
New +$98K 0.02% 512
2020
Q3 		– Sell
-1,224
Closed -$13.7M – 8866
2020
Q2 		$13.7M Sell
1,224
-624
-34% -$66.2K 0.02% 402
2020
Q1 		$16.6M Buy
1,848
+699
+61% +$68.6K 0.03% 274
2019
Q4 		$12.4M Sell
1,149
-123
-10% -$13.2K 0.03% 397
2019
Q3 		$12.5M Sell
1,272
-17
-1% -$1.92K 0.04% 350
2019
Q2 		$16.9M Sell
1,289
-642
-33% -$82.7K 0.05% 265
2019
Q1 		$26.1M Buy
1,931
+1,385
+254% +$172K 0.07% 167
2018
Q4 		$5.32M Buy
546
+302
+124% +$35.7K 0.02% 540
2018
Q3 		$3.39M Sell
244
-330
-57% -$41.4K 0.01% 851
2018
Q2 		$7.13M Sell
574
-518
-47% -$60.5K 0.03% 442
2018
Q1 		$1.35M Buy
1,092
+390
+56% +$46.6K 0.06% 283
2017
Q4 		$628K Sell
702
-556
-44% -$67.7K 0.03% 602
2017
Q3 		$225K Sell
1,258
-127
-9% -$17.3K 0.01% 1115
2017
Q2 		$440K Buy
1,385
+1,114
+411% +$130K 0.02% 718
2017
Q1 		$136K Sell
271
-449
-62% -$57.9K 0.01% 1495
2016
Q4 		$394K Sell
720
-43
-6% -$5.26K 0.02% 659
2016
Q3 		$538K Buy
763
+118
+18% +$15.2K 0.04% 469
2016
Q2 		$748K Buy
645
+522
+424% +$74.1K 0.05% 376
2016
Q1 		$94K Sell
123
-139
-53% -$20.4K 0.01% 1415
2015
Q4 		$110K Sell
262
-356
-58% -$62.2K 0.01% 1279
2015
Q3 		$461K Sell
618
-268
-30% -$48.9K 0.03% 477
2015
Q2 		$221K Buy
886
+625
+239% +$108K 0.02% 754
2015
Q1 		$96K Buy
+261
New +$47.2K 0.01% 1122

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Simplex Trading's ALXN Position: Q3 2021 in Review

Simplex Trading sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 18,712 shares — an estimated $3.44M sold.

Simplex Trading first reported a position in ALXN in Q4 2014 and held it in 23 quarters. The position peaked at $12.8M in Q4 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Simplex Trading reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Simplex Trading sold 18,712 Alexion Pharmaceuticals shares in Q3 2021, an estimated $3.44M.
  • Simplex Trading first reported a position in Alexion Pharmaceuticals in Q4 2014 and held it in 23 quarters.
  • Simplex Trading's Alexion Pharmaceuticals position peaked at $12.8M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Simplex Trading's 13F filing for Q3 2021, filed 28 Oct 2021.